Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...
Similar findings with no significant association seen when accounting for hormone therapy status and duration of use.
Researchers compare nivolumab as monotherapy or in combination with chemotherapy vs conventional treatment on overall survival and progression-free survival in patients with advanced unresectable ...
A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.
Both regimens “can be considered standard chemotherapy options” for high-risk, HR-positive early breast cancer, said Sherko Kuemmel, MD, PhD.
NP-101 plus nivolumab and ipilimumab demonstrated activity in patients with metastatic EP-NECs that were refractory to chemotherapy.
A cross-sectional study of nurses explored the mediating factors behind their attitudes toward seeking psychological help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback